Ideal Life raised capital from Abraxis BioScience
About Ideal Life:
Ideal Life was a pioneering remote patient monitoring service with 20 years of experience managing collectively over 100,000 monitored patients. Ideal Life was acquired by Raziel Health in March 2020.
About Abraxis BioScience:
Abraxis BioScience was a global biopharmaceutical company that developed treatments for critically ill patients. It had over 2000 employees worldwide in 2007. Abraxis’s portfolio included the world’s first protein-based nanoparticle chemotherapeutic compound, called nab Technology. The company developed Abraxane, a treatment for metastatic breast cancer. In 2010, Abraxis BioScience was acquired by Celgene Corporation.